Effect of cilostazol on endothelial function and platelet function in patients receiving clopidogrel
Not Applicable
- Conditions
- on-cardiogenic brain infarction
- Registration Number
- JPRN-UMIN000026672
- Lead Sponsor
- Tokyo Women's Medical Univeristy
- Brief Summary
FMD in brachial artery was similar between at baseline and after 6 months in the control group. In contrast, FMD significantly increased from baseline to 7 after 6 months in the cilostazol group ( p = 0.019).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who take aspirin or oral anti-coagulant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Flow-mediated dilatation (% FMD) 2. Thrombus formation and platelet aggregability
- Secondary Outcome Measures
Name Time Method